Replies to post #183581 on Anavex Life Sciences Corp (AVXL)

[georgejjl]

Experimental: ANAVEX2-73 Oral as assigned in ANAVEX2-73-002

https://www.clinicaltrials.gov/ct2/show/NCT02756858?term=anavex&rank=5

Good luck and GOD bless,

[F1ash]

Answering that simple question seems to require a bit of sleuthing and still requires an educated guess.

From the Australian registration for AD


Treatment: Drugs - High dose ANAVEX2-73
Treatment: Drugs - Mid dose ANAVEX2-73
Treatment: Drugs - Placebo oral capsule


https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=17993&isClinicalTrial=True



For the PDD study


ANAVEX2-73 Study in Parkinson's Disease Dementia

Drug: High dose ANAVEX2-73
Drug: Mid dose ANAVEX2-73
Drug: Placebo oral capsule


https://clinicaltrials.gov/ct2/show/NCT03774459?term=Anavex&rank=2

What the high and low dose actually represent for the EU PDD trial


Concentration unit mg milligram(s)

Concentration number 10
Concentration number 20

https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-004335-36/ES

Are they only administering 10 and 20 mgs as the High and Mid dose in the AD trial?